Abstract
Patients with periodontitis have higher risk of alveolar bone loss when seek for orthodontic therapy. Inflammation and osteogenesis are key factors in alveolar bone destruction in periodontitis and orthodontic tooth movement (OTM). Here we evaluated the effects of irisin on alveolar bone destruction in rats with periodontitis and OTM. We isolated and cultured human periodontal ligament stem cells (PDLSCs). Irisin was administrated to PDLSCs. Cell proliferations, osteogenic differentiation, expression of RUNX2 and ALP, and the expression of OPG and RANKL were measured. We induced periodontitis and OTM in rats and treated rats with irisin. The alveolar bone loss, inflammatory cytokine levels, and expression of OPG and RANKL in gingival tissues were measured. Irisin promoted the cell proliferation and osteogenic differentiation of PDLSCs. Irisin elevated the expression of RUNX2, ALP, and OPG while decreased the expression of RANKL in PDLSCs. Irisin ameliorated the alveolar bone loss, suppressed cytokine levels, and increased OPG/RANKL expression ratio in rat with periodontitis and orthodontic tooth movement. Irisin prevented alveolar bone destruction during OTM in rats with periodontitis.
Similar content being viewed by others
DATA AVAILABILITY
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.
References
Kononen, E., M. Gursoy, and U.K. Gursoy. 2019. Periodontitis: a multifaceted disease of tooth-supporting tissues. Journal of Clinical Medicine 8.
Kassebaum, N.J., E. Bernabe, M. Dahiya, B. Bhandari, C.J. Murray, and W. Marcenes. 2014. Global burden of severe periodontitis in 1990–2010: A systematic review and meta-regression. Journal of Dental Research 93: 1045–1053.
Pini Prato, G.P., and L. Chambrone. 2020. Orthodontic treatment in periodontal patients: The use of periodontal gold standards to overcome the “grey zone.” Journal of Periodontology 91: 437–441.
Gkantidis, N., P. Christou, and N. Topouzelis. 2010. The orthodontic-periodontic interrelationship in integrated treatment challenges: A systematic review. Journal of Oral Rehabilitation 37: 377–390.
Li, Y., L.A. Jacox, S.H. Little, and C.C. Ko. 2018. Orthodontic tooth movement: The biology and clinical implications. Kaohsiung Journal of Medical Sciences 34: 207–214.
Theoleyre, S., Y. Wittrant, S.K. Tat, Y. Fortun, F. Redini, and D. Heymann. 2004. The molecular triad OPG/RANK/RANKL: Involvement in the orchestration of pathophysiological bone remodeling. Cytokine & Growth Factor Reviews 15: 457–475.
Belibasakis, G.N., and N. Bostanci. 2012. The RANKL-OPG system in clinical periodontology. Journal of Clinical Periodontology 39: 239–248.
Arhire, L.I., L. Mihalache, and M. Covasa. 2019. Irisin: A hope in understanding and managing obesity and metabolic syndrome. Front Endocrinol (Lausanne) 10: 524.
Colaianni, G., L. Sanesi, G. Storlino, G. Brunetti, S. Colucci, and M. Grano. 2019. Irisin and bone: from preclinical studies to the evaluation of its circulating levels in different populations of human subjects. Cells 8.
Lourenco, M.V., R.L. Frozza, G.B. de Freitas, H. Zhang, G.C. Kincheski, F.C. Ribeiro, et al. 2019. Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer’s models. Nature Medicine 25: 165–175.
Polyzos, S.A., A.D. Anastasilakis, Z.A. Efstathiadou, P. Makras, N. Perakakis, J. Kountouras, et al. 2018. Irisin in metabolic diseases. Endocrine 59: 260–274.
Hu, S., Y. Xue, J. He, C. Chen, J. Sun, Y. Jin, et al. 2021. Irisin recouples osteogenesis and osteoclastogenesis to protect wear-particle-induced osteolysis by suppressing oxidative stress and RANKL production. Biomater Sci 9: 5791–5801.
Chen, Z., Y. Zhang, F. Zhao, C. Yin, C. Yang, X. Wang, et al. 2020. Recombinant irisin prevents the reduction of osteoblast differentiation induced by stimulated microgravity through increasing beta-catenin expression. International Journal of Molecular Science 21.
Colucci, S.C., C. Buccoliero, L. Sanesi, M. Errede, G. Colaianni, T. Annese, et al. 2021. Systemic administration of recombinant irisin accelerates fracture healing in mice. International Journal of Molecular Science 22.
Park, J.C., J.M. Kim, I.H. Jung, J.C. Kim, S.H. Choi, K.S. Cho, et al. 2011. Isolation and characterization of human periodontal ligament (PDL) stem cells (PDLSCs) from the inflamed PDL tissue: In vitro and in vivo evaluations. Journal of Clinical Periodontology 38: 721–731.
Zhang, C., T. Li, C. Zhou, L. Huang, Y. Li, H. Wang, et al. 2020. Parathyroid hormone increases alveolar bone homoeostasis during orthodontic tooth movement in rats with periodontitis via crosstalk between STAT3 and beta-catenin. International Journal of Oral Science 12: 38.
Satomi, K., K. Nishimura, and K. Igarashi. 2022. Semaphorin 3A protects against alveolar bone loss during orthodontic tooth movement in mice with periodontitis. Journal of Periodontal Research 57: 991–1002.
Yasuda, H., N. Shima, N. Nakagawa, K. Yamaguchi, M. Kinosaki, S. Mochizuki, et al. 1998. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proceedings of the National Academy of Sciences USA 95: 3597–3602.
Bucay, N., I. Sarosi, C.R. Dunstan, S. Morony, J. Tarpley, C. Capparelli, et al. 1998. osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes & Development 12: 1260–1268.
Mizuno, A., N. Amizuka, K. Irie, A. Murakami, N. Fujise, T. Kanno, et al. 1998. Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin. Biochemical and Biophysical Research Communications 247: 610–615.
Liu, D., J.K. Xu, L. Figliomeni, L. Huang, N.J. Pavlos, M. Rogers, et al. 2003. Expression of RANKL and OPG mRNA in periodontal disease: Possible involvement in bone destruction. International Journal of Molecular Medicine 11: 17–21.
Ogasawara, T., Y. Yoshimine, T. Kiyoshima, I. Kobayashi, K. Matsuo, A. Akamine, et al. 2004. In situ expression of RANKL, RANK, osteoprotegerin and cytokines in osteoclasts of rat periodontal tissue. Journal of Periodontal Research 39: 42–49.
Qiao, X., Y. Nie, Y. Ma, Y. Chen, R. Cheng, W. Yin, et al. 2016. Irisin promotes osteoblast proliferation and differentiation via activating the MAP kinase signaling pathways. Science and Reports 6: 18732.
Ma, Y., X. Qiao, R. Zeng, R. Cheng, J. Zhang, Y. Luo, et al. 2018. Irisin promotes proliferation but inhibits differentiation in osteoclast precursor cells. FASEB Journal fj201700983RR.
Usui, M., S. Onizuka, T. Sato, S. Kokabu, W. Ariyoshi, and K. Nakashima. 2021. Mechanism of alveolar bone destruction in periodontitis - Periodontal bacteria and inflammation. Japanese Dental Science Review 57: 201–208.
Yamaguchi, M., and S. Fukasawa. 2021. Is Inflammation a friend or foe for orthodontic treatment?: inflammation in orthodontically induced inflammatory root resorption and accelerating tooth movement. International Journal of Molecular Science 22.
Bletsa, A., E. Berggreen, and P. Brudvik. 2006. Interleukin-1alpha and tumor necrosis factor-alpha expression during the early phases of orthodontic tooth movement in rats. European Journal of Oral Sciences 114: 423–429.
Ren, Y., and A. Vissink. 2008. Cytokines in crevicular fluid and orthodontic tooth movement. European Journal of Oral Sciences 116: 89–97.
Lo, Y.J., C.M. Liu, M.Y. Wong, L.T. Hou, and W.K. Chang. 1999. Interleukin 1beta-secreting cells in inflamed gingival tissue of adult periodontitis patients. Cytokine 11: 626–633.
Irwin, C.R., and T.T. Myrillas. 1998. The role of IL-6 in the pathogenesis of periodontal disease. Oral Diseases 4: 43–47.
Lee, H.J., I.K. Kang, C.P. Chung, and S.M. Choi. 1995. The subgingival microflora and gingival crevicular fluid cytokines in refractory periodontitis. Journal of Clinical Periodontology 22: 885–890.
Zhu, W., N.E. Sahar, H.M.A. Javaid, E.S. Pak, G. Liang, Y. Wang, et al. 2021. Exercise-induced irisin decreases inflammation and improves NAFLD by competitive binding with MD2. Cells 10.
Mazur-Bialy, A.I., E. Pochec, and M. Zarawski. 2017. Anti-inflammatory properties of irisin, mediator of physical activity, are connected with TLR4/MyD88 signaling pathway activation. International Journal of Molecular Science 18.
Author information
Authors and Affiliations
Contributions
Shuainan Wu: data curation, conceptualization, methodology, writing—original draft preparation, investigation, methodology, writing—reviewing and editing. Jianqi Wang: data curation, software, validation. Lu Liu: visualization, data curation. Ying Pang: data curation, conceptualization, writing—original draft preparation, supervision, writing—reviewing and editing. Zhaobao Li: conceptualization, visualization, data curation. Hong Mu: conceptualization, visualization, data curation.
Corresponding author
Ethics declarations
Ethical Approval
The study was reviewed and approved by the ethics committee of Cangzhou Central Hospital.
Consent for Publication
Current study is available from the corresponding author on reasonable request.
Competing Interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Wu, S., Wang, J., Liu, L. et al. Recombinant Irisin Protects Against Alveolar Bone Destruction During Orthodontic Tooth Movement. Inflammation 46, 1106–1117 (2023). https://doi.org/10.1007/s10753-023-01797-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-023-01797-3